JongHeungDang Cefaclore Dry Syrup 25mg/mL
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
JongHeungDang Co., Ltd.
MFDS item code 199700184 · Notified 1997.07.23 · Insurance code 643302801
Treatment of respiratory and urinary tract infections such as otitis media and pneumonia
This drug is effective against various bacterial infections such as Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Escherichia coli. It is mainly used for respiratory infections, including otitis media, pneumonia, pharyngitis, and tonsillitis. It also aids in the treatment of urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. It is effective for skin infections including furuncles, carbuncles, folliculitis, soft tissue infections, and wound infections. It is widely used for various bacterial infections to improve symptoms.
For cefaclor, administer 250mg (based on potency) every 8 hours orally. In cases of severe infections (such as pneumonia) and infections with low sensitivity, the dose may be doubled. For acute gonococcal urethritis, administer 3g of this drug along with 1g of probenecid in a single dose.
Administer 20mg (based on potency) per kg of body weight every 8 hours. In cases of severe infections, otitis media, and infections with low sensitivity, a dosage of 40mg (based on potency) per kg of body weight may be given, with a maximum dosage of
This drug is an antibiotic that kills bacteria by destroying the cell wall of certain bacteria. It should never be administered to patients who have had severe allergic reactions or shock while using this medication before. Patients with allergies to this drug or to cephalosporin antibiotics should also avoid this medication. Caution should be exercised when administering to patients with a history of allergies to penicillin antibiotics, patients with allergic constitution, severely impaired kidney function, patients who have difficulties with oral intake or are elderly, and those with a history of gastrointestinal diseases. This drug may rarely cause severe allergic reactions such as shock or anaphylaxis, so careful monitoring of symptoms during administration is necessary. If severe rashes, blisters, mucosal damage, etc., occur, discontinue use immediately and seek treatment. Regular blood tests are necessary as it may show decreased white blood cells, platelets, or anemia, and should be discontinued if any abnormal signs appear. Liver dysfunction or decreased kidney function may occur, so liver and kidney function tests should be performed regularly, and the drug should be discontinued if the condition worsens. Gastrointestinal side effects such as diarrhea, abdominal pain, and discomfort may occur, and if severe colitis symptoms arise, discontinue the medication immediately. Respiratory symptoms or central nervous system symptoms (anxiety, dizziness, hallucinations, etc.) may occur, so careful observation is required. This drug may cause vitamin K deficiency, posing a bleeding risk, so it should be used with particular caution in elderly patients or those with a tendency to bleed. This drug may interact with other medications, particularly probenecid, nephrotoxic drugs, diuretics, anticoagulants, and oral contraceptives, so it must be administered cautiously under professional guidance when used together. Pregnant or breastfeeding women should only use this drug when absolutely necessary, as its safety is not fully established; when breastfeeding, they should administer it cautiously considering the impact on the baby. The safety and efficacy in newborns, especially those under one month old, have not been established, so it is advisable not to use it. Elderly patients may experience side effects more readily due to declining body functions, so dosage and administration intervals should be adjusted while closely monitoring the condition. During administration of this drug, some urine tests may yield false-positive results, so caution is required in interpretation of test results.
Hives, shock, anaphylactic symptoms (including dyspnea and vascular swelling), Stevens-Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, granulocytopenia, pancytopenia, anemia, thrombocytopenia, aplastic anemia, hemolytic anemia, reversible neutropenia, hepatitis, jaundice, elevation of AST, ALT, ALP, reversible interstitial nephritis, elevated BUN and serum creatinine, acute renal failure, and severe colitis with bloody stool.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to light and should be stored in a light-blocking container. Additionally, it is best to keep the medication at room temperature, neither too hot nor too cold, in order to maintain its effectiveness for a longer period.
It is a pink dry syrup that dissolves when used.
100 mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
JongHeungDang Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.